On the surface of carcinoma cells which have adhered to the endothelium, the CD44 receptor anchors activated MMP-9 and redistributes it at the invading edge of tumor cells, together with the highly proteolytic MT1-MMP [78]. This evidence concerns the gene MMP9 and carcinoma.